Literature DB >> 24924172

RECQ DNA helicases and osteosarcoma.

Linchao Lu1, Weidong Jin, Hao Liu, Lisa L Wang.   

Abstract

The RECQ family of DNA helicases is a conserved group of enzymes that are important for maintaining genomic integrity. In humans, there are five RECQ helicase genes, and mutations in three of them-BLM, WRN, and RECQL4-are associated with the genetic disorders Bloom syndrome, Werner syndrome, and Rothmund-Thomson syndrome (RTS), respectively. Importantly all three diseases are cancer predisposition syndromes. Patients with RTS are highly and uniquely susceptible to developing osteosarcoma; thus, RTS provides a good model to study the pathogenesis of osteosarcoma. The "tumor suppressor" role of RECQL4 and the other RECQ helicases is an area of active investigation. This chapter reviews what is currently known about the cellular functions of RECQL4 and how these may relate to tumorigenesis, as well as ongoing efforts to understand RECQL4's functions in vivo using animal models. Understanding the RECQ pathways may provide insight into avenues for novel cancer therapies in the future.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24924172     DOI: 10.1007/978-3-319-04843-7_7

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  16 in total

Review 1.  Osteosarcoma: Molecular Pathogenesis and iPSC Modeling.

Authors:  Yu-Hsuan Lin; Brittany E Jewell; Julian Gingold; Linchao Lu; Ruiying Zhao; Lisa L Wang; Dung-Fang Lee
Journal:  Trends Mol Med       Date:  2017-07-20       Impact factor: 11.951

2.  [Hereditary bone tumors].

Authors:  D Baumhoer
Journal:  Pathologe       Date:  2017-05       Impact factor: 1.011

3.  RECQL4 Promotes DNA End Resection in Repair of DNA Double-Strand Breaks.

Authors:  Huiming Lu; Raghavendra A Shamanna; Guido Keijzers; Roopesh Anand; Lene Juel Rasmussen; Petr Cejka; Deborah L Croteau; Vilhelm A Bohr
Journal:  Cell Rep       Date:  2016-06-16       Impact factor: 9.423

Review 4.  [Pathogenesis and genetics of osteosarcoma : Current concepts and developments].

Authors:  D Baumhoer
Journal:  Pathologe       Date:  2018-03       Impact factor: 1.011

Review 5.  Targeting Molecular Mechanisms Underlying Treatment Efficacy and Resistance in Osteosarcoma: A Review of Current and Future Strategies.

Authors:  Ingrid Lilienthal; Nikolas Herold
Journal:  Int J Mol Sci       Date:  2020-09-19       Impact factor: 5.923

6.  The DNA helicase recql4 is required for normal osteoblast expansion and osteosarcoma formation.

Authors:  Alvin J M Ng; Mannu K Walia; Monique F Smeets; Anthony J Mutsaers; Natalie A Sims; Louise E Purton; Nicole C Walsh; T John Martin; Carl R Walkley
Journal:  PLoS Genet       Date:  2015-04-10       Impact factor: 5.917

7.  Rothmund-Thomson Syndrome: novel pathogenic mutations and frequencies of variants in the RECQL4 and USB1 (C16orf57) gene.

Authors:  Aude-Annick Suter; Peter Itin; Karl Heinimann; Munaza Ahmed; Tazeen Ashraf; Helen Fryssira; Usha Kini; Pablo Lapunzina; Peter Miny; Mette Sommerlund; Mohnish Suri; Signe Vaeth; Pradeep Vasudevan; Sabina Gallati
Journal:  Mol Genet Genomic Med       Date:  2016-02-24       Impact factor: 2.183

Review 8.  Biology of Bone Sarcomas and New Therapeutic Developments.

Authors:  Hannah K Brown; Kristina Schiavone; François Gouin; Marie-Françoise Heymann; Dominique Heymann
Journal:  Calcif Tissue Int       Date:  2017-12-13       Impact factor: 4.333

9.  Exome sequencing of osteosarcoma reveals mutation signatures reminiscent of BRCA deficiency.

Authors:  Michal Kovac; Claudia Blattmann; Sebastian Ribi; Jan Smida; Nikola S Mueller; Florian Engert; Francesc Castro-Giner; Joachim Weischenfeldt; Monika Kovacova; Andreas Krieg; Dimosthenis Andreou; Per-Ulf Tunn; Hans Roland Dürr; Hans Rechl; Klaus-Dieter Schaser; Ingo Melcher; Stefan Burdach; Andreas Kulozik; Katja Specht; Karl Heinimann; Simone Fulda; Stefan Bielack; Gernot Jundt; Ian Tomlinson; Jan O Korbel; Michaela Nathrath; Daniel Baumhoer
Journal:  Nat Commun       Date:  2015-12-03       Impact factor: 17.694

10.  Multiple Low Energy Long Bone Fractures in the Setting of Rothmund-Thomson Syndrome.

Authors:  Nicholas Beckmann
Journal:  Case Rep Med       Date:  2015-11-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.